These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25906670)

  • 1. Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
    Schuchard J; Winkler M; Stölting I; Schuster F; Vogt FM; Barkhausen J; Thorns C; Santos RA; Bader M; Raasch W
    Br J Pharmacol; 2015 Aug; 172(15):3764-78. PubMed ID: 25906670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
    Müller-Fielitz H; Hübel N; Mildner M; Vogt FM; Barkhausen J; Raasch W
    Br J Pharmacol; 2014 Feb; 171(3):746-60. PubMed ID: 24490862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats.
    Winkler M; Schuchard J; Stölting I; Vogt FM; Barkhausen J; Thorns C; Bader M; Raasch W
    Br J Pharmacol; 2016 May; 173(10):1602-17. PubMed ID: 26892671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrarenal Mas and AT
    O'Neill J; Healy V; Johns EJ
    Exp Physiol; 2017 Dec; 102(12):1700-1715. PubMed ID: 28940861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.
    Müller-Fielitz H; Lau M; Geißler C; Werner L; Winkler M; Raasch W
    Br J Pharmacol; 2015 Feb; 172(3):857-68. PubMed ID: 25258168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAS receptors mediate vasoprotective and atheroprotective effects of candesartan upon the recovery of vascular angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis functionality.
    Pernomian L; do Prado AF; Gomes MS; Pernomian L; da Silva CHTP; Gerlach RF; de Oliveira AM
    Eur J Pharmacol; 2015 Oct; 764():173-188. PubMed ID: 26144375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiobese effect of AT1 receptor blockade is augmented in mice lacking Mas.
    Dapper C; Schuster F; Stölting I; Vogt F; Castro E Souza LA; Alenina N; Bader M; Raasch W
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jul; 392(7):865-877. PubMed ID: 30868173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
    Giani JF; Gironacci MM; Muñoz MC; Peña C; Turyn D; Dominici FP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1154-63. PubMed ID: 17496209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
    Sugimoto K; Qi NR; Kazdová L; Pravenec M; Ogihara T; Kurtz TW
    Hypertension; 2006 May; 47(5):1003-9. PubMed ID: 16567593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
    Aubert G; Burnier M; Dulloo A; Perregaux C; Mazzolai L; Pralong F; Zanchi A
    Metabolism; 2010 Jan; 59(1):25-32. PubMed ID: 19793594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade.
    Abuohashish HM; Ahmed MM; Sabry D; Khattab MM; Al-Rejaie SS
    Eur J Pharmacol; 2017 Jul; 807():44-55. PubMed ID: 28442323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
    Miesel A; Müller-Fielitz H; Jöhren O; Vogt FM; Raasch W
    Br J Pharmacol; 2012 Apr; 165(8):2721-35. PubMed ID: 22014027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-(1-7) contributes to insulin-sensitizing effects of angiotensin-converting enzyme inhibition in obese mice.
    Loloi J; Miller AJ; Bingaman SS; Silberman Y; Arnold AC
    Am J Physiol Endocrinol Metab; 2018 Dec; 315(6):E1204-E1211. PubMed ID: 30300010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Ptak-Belowska A; Pajdo R; Olszanecki R; Suski M; Madej J; Targosz A; Konturek SJ; Korbut R; Brzozowski T
    J Physiol Pharmacol; 2016 Feb; 67(1):75-91. PubMed ID: 27010897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Mas receptor antagonist (A779) in renal hemodynamics in condition of blocked angiotensin II receptors in rats.
    Mansoori A; Oryan S; Nematbakhsh M
    Physiol Int; 2016 Mar; 103(1):13-20. PubMed ID: 27030624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation.
    Müller-Fielitz H; Landolt J; Heidbreder M; Werth S; Vogt FM; Jöhren O; Raasch W
    Endocrinology; 2012 Mar; 153(3):1103-15. PubMed ID: 22253423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
    Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
    Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).
    Muñoz MC; Giani JF; Burghi V; Mayer MA; Carranza A; Taira CA; Dominici FP
    Regul Pept; 2012 Aug; 177(1-3):1-11. PubMed ID: 22561450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of AT1 and Mas receptors in the modulation of inflammatory pain.
    Costa AC; Romero TR; Pacheco DF; Perez AC; Savernini A; Santos RR; Duarte ID
    Peptides; 2014 Nov; 61():17-22. PubMed ID: 25169953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect.
    Beckmann L; Künstner A; Freschi ML; Huber G; Stölting I; Ibrahim SM; Hirose M; Freitag M; Langan EA; Matschl U; Galuska CE; Fuchs B; Knobloch JK; Busch H; Raasch W
    Pharmacol Res; 2021 Aug; 170():105724. PubMed ID: 34116209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.